BERTINARIA, Massimo
BERTINARIA, Massimo
SCIENZA E TECNOLOGIA DEL FARMACO
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties
2003-01-01 BERTINARIA M; DI STILO A; TOSCO P; SORBA G; POLI E; POZZOLI C; CORUZZI G; FRUTTERO R; GASCO A
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
2018-01-01 Carolina Pellegrini, Matteo Fornai, Rocchina Colucci, Laura Benvenuti, Vanessa D’Antongiovanni, Gianfranco Natale, Federica Fulceri, Marta Giorgis, Elisabetta Marini, Simone Gastaldi, Massimo Bertinaria, Corrado Blandizzi, Luca Antonioli
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity
2013-01-01 Malvina Hoxha; Valerie Capra; Carola Buccellati; Angelo Sala; Mohammed Abrar Abdul Gaffar Shaikh; Clara Cena; Roberta Fruttero; Alberto Gasco; G. Enrico Rovati; Massimo Bertinaria
A new class of NO-donor H3-Antagonists
2004-01-01 P. Tosco; M. Bertinaria; A. Di Stilo; E. Marini; B. Rolando; G. Sorba; R. Fruttero; A. Gasco
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile
2014-01-01 Hoxha, M.; Capra, V.; Buccellati, C.; Sala, A.; Cena, C.; Fruttero, R.; Bertinaria, M.; Rovati, G.E.
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity
2009-01-01 Stefano Guglielmo; Massimo Bertinaria; Barbara Rolando; Marco Crosetti; Roberta Fruttero; Vanessa Yardley; Simon L. Croft; Alberto Gasco
A rapid screening for cytochromes P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives
2013-01-01 G.E. Tsotsou; G. Di Nardo; S.J. Sadeghi; R. Fruttero; L. Lazzarato; M. Bertinaria ; G. Gilardi
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria
2011-01-01 Massimo Bertinaria; Stefano Guglielmo; Barbara Rolando; Marta Giorgis; Cristina Aragno; Roberta Fruttero; Alberto Gasco; Silvia Parapini; Donatella Taramelli; Yuri C. Martins; Leonardo J.M. Carvalho
Amphiphilic NO-Donor Antioxidants
2007-01-01 K. CHEGAEV; L. LAZZARATO; B. ROLANDO; E. MARINI; G.V. LOPEZ; M. BERTINARIA; A. DI STILO; R. FRUTTERO; A. GASCO
Anti-Helicobacter pylori Agents Endowed with H2-antagonist Properties
2001-01-01 G. SORBA; M. BERTINARIA; A. DI STILO; A. GASCO; M.M. SCALTRITO; M.I. BRENCIAGLIA; F. DUBINI
Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties
2000-01-01 G.CORUZZI; M. ADAMI; G. MORINI; C. POZZOLI; C. CENA; M. BERTINARIA; A. GASCO
Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-7
2020-01-01 Gutschow M.; Eynde J.J.V.; Jampilek J.; Kang C.; Mangoni A.A.; Fossa P.; Karaman R.; Trabocchi A.; Scott P.J.H.; Reynisson J.; Rapposelli S.; Galdier S.; Winum J.-Y.; Brullo C.; Prokai-Tatrai K.; Sharma A.K.; Schapira M.; Azuma Y.-T.; Cerchia L.; Spete M.; Torri G.; Collina S.; Geronikaki A.; Garcia-Sosa A.T.; Helena Vasconcelos M.; Sousa M.E.; Kosalec I.; Tuccinardi T.; Duarte I.F.; Salvador J.A.R.; Bertinaria M.; Pellecchia M.; Amato J.; Rastelli G.; Gomes P.A.C.; Guedes R.C.; Sabatier J.-M.; Estevez-Braun A.; Pagano B.; Mangani S.; Ragno R.; Kokotos G.; Brindisi M.; Gonzalez F.V.; Borges F.; Miloso M.; Rautio J.; Munoz-Torrero D.
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation
2016-01-01 Spallotta, F; Cencioni, C; Atlante, S; Garella, D; Cocco, M; Mori, M; Mastrocola, R; Kuenne, C; Guenther, S; Nanni, S; Azzimato, V; Zukunft, S; Kornberger, A; Di Stilo, A; Aragno, M; Martelli, F; Farsetti, A; Fleming, I; Braun, T; Beiras-Fernandez, A; Botta, B; Collino, M; Bertinaria, M; Zeiher, Am; Gaetano, C.
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile
2012-01-01 Bertinaria M; Rolando B; Giorgis M; Montanaro G; Marini E; Collino M; Benetti E; Daniele PG; Fruttero R; Gasco A.
Carnosine analogues containing Phenol substructures
2012-01-01 Giorgis M.; Bertinaria M.; Rolando B.; Montanaro G.; Fruttero R.; Gasco A.
Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor
2021-01-01 Gastaldi S.; Boscaro V.; Gianquinto E.; Sandall C.F.; Giorgis M.; Marini E.; Blua F.; Gallicchio M.; Spyrakis F.; Macdonald J.A.; Bertinaria M.
Composti ibridi per il trattamento della malaria cerebrale
2013-01-01 Leonardo Jose de Moura Carvalho; Alberto Gasco; Roberta Fruttero; Massimo Bertinaria
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO
2021-01-01 BLANDIZZI CORRADO, PELLEGRINI CAROLINA, FORNAI MATTEO, ANTONIOLI LUCA, COLUCCI ROCCHINA, BERTINARIA MASSIMO, MARINI ELISABETTA, BOSCARO VALENTINA, GASTALDI SIMONE, COCCO MATTIA
Design and synthesis of encorafenib-based BRAF-V600E degraders
2022-01-01 Federica Blua, Marco Marino, Simone Gastaldi, Federica Maione, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Design and synthesis of INF195, a new NLRP3 Inflammasome Inhibitor with ex vivo cardioprotective effect
2024-01-01 Francesca Boccato, Simone Gastaldi, Magalì Giordano, Elisabetta Marini, Francesca Spyrakis, Pasquale Pagliaro, Claudia Penna, Massimo Bertinaria
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties | 2003 | BERTINARIA M; DI STILO A; TOSCO P; SORBA G; POLI E; POZZOLI C; CORUZZI G; FRUTTERO R; GASCO A | |
| A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation | 2018 | Carolina Pellegrini, Matteo Fornai, Rocchina Colucci, Laura Benvenuti, Vanessa D’Antongiovanni, Gianfranco Natale, Federica Fulceri, Marta Giorgis, Elisabetta Marini, Simone Gastaldi, Massimo Bertinaria, Corrado Blandizzi, Luca Antonioli | |
| A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity | 2013 | Malvina Hoxha; Valerie Capra; Carola Buccellati; Angelo Sala; Mohammed Abrar Abdul Gaffar Shaikh; Clara Cena; Roberta Fruttero; Alberto Gasco; G. Enrico Rovati; Massimo Bertinaria | |
| A new class of NO-donor H3-Antagonists | 2004 | P. Tosco; M. Bertinaria; A. Di Stilo; E. Marini; B. Rolando; G. Sorba; R. Fruttero; A. Gasco | |
| A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile | 2014 | Hoxha, M.; Capra, V.; Buccellati, C.; Sala, A.; Cena, C.; Fruttero, R.; Bertinaria, M.; Rovati, G.E. | |
| A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity | 2009 | Stefano Guglielmo; Massimo Bertinaria; Barbara Rolando; Marco Crosetti; Roberta Fruttero; Vanessa Yardley; Simon L. Croft; Alberto Gasco | |
| A rapid screening for cytochromes P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives | 2013 | G.E. Tsotsou; G. Di Nardo; S.J. Sadeghi; R. Fruttero; L. Lazzarato; M. Bertinaria ; G. Gilardi | |
| Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria | 2011 | Massimo Bertinaria; Stefano Guglielmo; Barbara Rolando; Marta Giorgis; Cristina Aragno; Roberta Fruttero; Alberto Gasco; Silvia Parapini; Donatella Taramelli; Yuri C. Martins; Leonardo J.M. Carvalho | |
| Amphiphilic NO-Donor Antioxidants | 2007 | K. CHEGAEV; L. LAZZARATO; B. ROLANDO; E. MARINI; G.V. LOPEZ; M. BERTINARIA; A. DI STILO; R. FRUTTERO; A. GASCO | |
| Anti-Helicobacter pylori Agents Endowed with H2-antagonist Properties | 2001 | G. SORBA; M. BERTINARIA; A. DI STILO; A. GASCO; M.M. SCALTRITO; M.I. BRENCIAGLIA; F. DUBINI | |
| Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties | 2000 | G.CORUZZI; M. ADAMI; G. MORINI; C. POZZOLI; C. CENA; M. BERTINARIA; A. GASCO | |
| Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-7 | 2020 | Gutschow M.; Eynde J.J.V.; Jampilek J.; Kang C.; Mangoni A.A.; Fossa P.; Karaman R.; Trabocchi A.; Scott P.J.H.; Reynisson J.; Rapposelli S.; Galdier S.; Winum J.-Y.; Brullo C.; Prokai-Tatrai K.; Sharma A.K.; Schapira M.; Azuma Y.-T.; Cerchia L.; Spete M.; Torri G.; Collina S.; Geronikaki A.; Garcia-Sosa A.T.; Helena Vasconcelos M.; Sousa M.E.; Kosalec I.; Tuccinardi T.; Duarte I.F.; Salvador J.A.R.; Bertinaria M.; Pellecchia M.; Amato J.; Rastelli G.; Gomes P.A.C.; Guedes R.C.; Sabatier J.-M.; Estevez-Braun A.; Pagano B.; Mangani S.; Ragno R.; Kokotos G.; Brindisi M.; Gonzalez F.V.; Borges F.; Miloso M.; Rautio J.; Munoz-Torrero D. | |
| Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation | 2016 | Spallotta, F; Cencioni, C; Atlante, S; Garella, D; Cocco, M; Mori, M; Mastrocola, R; Kuenne, C; Guenther, S; Nanni, S; Azzimato, V; Zukunft, S; Kornberger, A; Di Stilo, A; Aragno, M; Martelli, F; Farsetti, A; Fleming, I; Braun, T; Beiras-Fernandez, A; Botta, B; Collino, M; Bertinaria, M; Zeiher, Am; Gaetano, C. | |
| Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile | 2012 | Bertinaria M; Rolando B; Giorgis M; Montanaro G; Marini E; Collino M; Benetti E; Daniele PG; Fruttero R; Gasco A. | |
| Carnosine analogues containing Phenol substructures | 2012 | Giorgis M.; Bertinaria M.; Rolando B.; Montanaro G.; Fruttero R.; Gasco A. | |
| Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor | 2021 | Gastaldi S.; Boscaro V.; Gianquinto E.; Sandall C.F.; Giorgis M.; Marini E.; Blua F.; Gallicchio M.; Spyrakis F.; Macdonald J.A.; Bertinaria M. | |
| Composti ibridi per il trattamento della malaria cerebrale | 2013 | Leonardo Jose de Moura Carvalho; Alberto Gasco; Roberta Fruttero; Massimo Bertinaria | |
| COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO | 2021 | BLANDIZZI CORRADO, PELLEGRINI CAROLINA, FORNAI MATTEO, ANTONIOLI LUCA, COLUCCI ROCCHINA, BERTINARIA MASSIMO, MARINI ELISABETTA, BOSCARO VALENTINA, GASTALDI SIMONE, COCCO MATTIA | |
| Design and synthesis of encorafenib-based BRAF-V600E degraders | 2022 | Federica Blua, Marco Marino, Simone Gastaldi, Federica Maione, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria | |
| Design and synthesis of INF195, a new NLRP3 Inflammasome Inhibitor with ex vivo cardioprotective effect | 2024 | Francesca Boccato, Simone Gastaldi, Magalì Giordano, Elisabetta Marini, Francesca Spyrakis, Pasquale Pagliaro, Claudia Penna, Massimo Bertinaria |